The announcement of financial results and corporate updates is a routine event for publicly traded companies. While it provides important information about the company's financial health and strategic direction, the impact on the stock price is neutral until specific details are revealed. Investors will be particularly interested in any updates on the company's progress in developing therapies for hematological malignancies.